VEXT.CN
Vext Science Inc
Price:  
0.11 
CAD
Volume:  
133,000.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VEXT.CN WACC - Weighted Average Cost of Capital

The WACC of Vext Science Inc (VEXT.CN) is 6.3%.

The Cost of Equity of Vext Science Inc (VEXT.CN) is 6.00%.
The Cost of Debt of Vext Science Inc (VEXT.CN) is 8.80%.

Range Selected
Cost of equity 5.30% - 6.70% 6.00%
Tax rate 23.90% - 28.40% 26.15%
Cost of debt 7.00% - 10.60% 8.80%
WACC 5.3% - 7.3% 6.3%
WACC

VEXT.CN WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.33 0.33
Additional risk adjustments 0.5% 1.0%
Cost of equity 5.30% 6.70%
Tax rate 23.90% 28.40%
Debt/Equity ratio 1.76 1.76
Cost of debt 7.00% 10.60%
After-tax WACC 5.3% 7.3%
Selected WACC 6.3%

VEXT.CN's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for VEXT.CN:

cost_of_equity (6.00%) = risk_free_rate (3.45%) + equity_risk_premium (5.60%) * adjusted_beta (0.33) + risk_adjustments (0.75%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.